Literature DB >> 2264889

A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.

H E Gendelman1, R M Friedman, S Joe, L M Baca, J A Turpin, G Dveksler, M S Meltzer, C Dieffenbach.   

Abstract

Interferon alpha (IFN-alpha) induces significant antiretroviral activities that affect the ability of human immunodeficiency virus (HIV) to infect and replicate in its principal target cells, CD4+ T cells and macrophages. A major endogenous source of IFN-alpha during any infection is the macrophage. Thus, macrophages have the potential to produce both IFN-alpha and HIV. In this study, we examined the production of IFN-alpha and other cytokines by macrophage colony-stimulating factor (M-CSF)-treated cultured monocytes during HIV infection. Tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), IL-6, IFN-omega, or IFN-beta were not detected nor was the mRNA expressed in either uninfected or HIV-infected monocytes. However, both uninfected and HIV-infected monocytes produced high levels of each of these cytokines after treatment with synthetic double-stranded RNA [poly(I).poly(C)]. Uninfected monocytes also produced high levels of IFN-alpha after treatment with poly(I).poly(C), Newcastle disease virus, or herpes simplex virus. In marked contrast to the preceding observations, HIV-infected monocytes produced little or no IFN-alpha before or after treatment with any of these agents. The absence of detectable IFN-alpha activity and mRNA in poly(I).poly(C)-treated HIV-infected monocytes was coincident with high levels of 2',5' oligoadenylate synthetase and complete ablation of HIV gene expression. The antiviral activity induced by poly(I).poly(C) may be a direct effect of this synthetic double-stranded RNA or secondary to the low levels of IFN-beta and IFN-omega produced by infected cells. The markedly diminished capacity of HIV-infected monocytes to produce IFN-alpha may reflect a specific adaptive mechanism of virus to alter basic microbicidal functions of this cell. The inevitable result of this HIV-induced cytokine dysregulation is virus replication and persistence in mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2264889      PMCID: PMC2188659          DOI: 10.1084/jem.172.5.1433

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  Varicella-zoster virus disease in patients with human immunodeficiency virus infection.

Authors:  R M Gulick; M Heath-Chiozzi; C S Crumpacker
Journal:  Arch Dermatol       Date:  1990-08

2.  Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress.

Authors:  S L Diamond; J B Sharefkin; C Dieffenbach; K Frasier-Scott; L V McIntire; S G Eskin
Journal:  J Cell Physiol       Date:  1990-05       Impact factor: 6.384

3.  Macrophage-HIV interaction: viral isolation and target cell tropism.

Authors:  H E Gendelman; L M Baca; H Husayni; J A Turpin; D Skillman; D C Kalter; J M Orenstein; D L Hoover; M S Meltzer
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

4.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

5.  The role of interferons in the control of HIV replication in macrophages.

Authors:  R S Kornbluth; P S Oh; J R Munis; P H Cleveland; D D Richman
Journal:  Clin Immunol Immunopathol       Date:  1990-02

6.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Authors:  D D Ho; T Moudgil; M Alam
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

7.  Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.

Authors:  H E Gendelman; L Baca; J A Turpin; D C Kalter; B D Hansen; J M Orenstein; R M Friedman; M S Meltzer
Journal:  AIDS Res Hum Retroviruses       Date:  1990-08       Impact factor: 2.205

8.  Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS.

Authors:  R Voth; S Rossol; K Klein; G Hess; K H Schütt; H C Schröder; K H Meyer zum Büschenfelde; W E Müller
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

9.  Automated, quantitative cytopathic effect reduction assay for interferon.

Authors:  T J Yeh; P T McBride; J C Overall; J A Green
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

10.  Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Authors:  H C Lane; V Davey; J A Kovacs; J Feinberg; J A Metcalf; B Herpin; R Walker; L Deyton; R T Davey; J Falloon
Journal:  Ann Intern Med       Date:  1990-06-01       Impact factor: 25.391

View more
  44 in total

1.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication.

Authors:  K Sofia Appelberg; Mark A Wallet; Jared P Taylor; Melanie N Cash; John W Sleasman; Maureen M Goodenow
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-12       Impact factor: 2.205

3.  Role of IgE immune complexes in the regulation of HIV-1 replication and increased cell death of infected U1 monocytes: involvement of CD23/Fc epsilon RII-mediated nitric oxide and cyclic AMP pathways.

Authors:  F Ouaaz; F W Ruscetti; B Dugas; J Mikovits; H Agut; P Debré; M D Mossalayi
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

4.  Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.

Authors:  A Bergamini; M Capozzi; L Ghibelli; L Dini; A Salanitro; G Milanese; T Wagner; S Beninati; C D Pesce; C Amici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

6.  HIV-1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes.

Authors:  Haitao Guo; Jianmei Gao; Debra J Taxman; Jenny P Y Ting; Lishan Su
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

7.  Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication.

Authors:  S Gessani; P Puddu; B Varano; P Borghi; L Conti; L Fantuzzi; F Belardelli
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Hantaan virus infection of human endothelial cells.

Authors:  M N Pensiero; J B Sharefkin; C W Dieffenbach; J Hay
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 9.  Innate immunity against HIV: a priority target for HIV prevention research.

Authors:  Persephone Borrow; Robin J Shattock; Annapurna Vyakarnam
Journal:  Retrovirology       Date:  2010-10-11       Impact factor: 4.602

10.  Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures.

Authors:  J Szebeni; C Dieffenbach; S M Wahl; C N Venkateshan; A Yeh; M Popovic; S Gartner; L M Wahl; M Peterfy; R M Friedman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.